Table 3.
Rate ratio relative to the occurrence of AIDS-defining illnesses 42 months after HAART initiation (Adult Senegalese cohort, 1998-2008, 293 patients).
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| Factors | Rate ratio | 95% CI | Rate ratio | 95% CI |
| Age (year) | 1.00 | [0.96;1.05] | ||
| Sex (female vs. male) | 0.52 | [0.25; 1.07] | ||
| Baseline CD4a | 0.95 | [0.82;1.10] | ||
| Baseline BMIb (kg/m2) | 0.90 | [0.80; 1.01] | ||
| CDC stage at baseline (C vs. A or B) | 1.77 | [0.77;4.09] | ||
| VLc ≤ 103 cp/mL at period start | 0.33 | [0.15;0.73] | ||
| Current CD4 cell counta | 0.80 | [0.74;0.87] | 0.79 | [0.71;0.87] |
| Variability in CD4 increased | 0.61 | [0.44;0.84] | ||
| Current viral load (≤ 103 vs. > 103 cp/mL) |
4.33 | [1.86;10.08] | 2.74 | [1.15;6.57] |
| Duration of VLc ≤ 103 cp/mL | 0.88 | [0.81; 0.96] | ||
a: per 50 cells/mm3; b: Body Mass Index; c: Viral Load; d: per standard deviation unit.